3-37025629-T-TTTTTTTA
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6
The NM_000249.4(MLH1):c.1039-8_1039-7insTTTTTTA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 19)
Exomes 𝑓: 0.000026 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MLH1
NM_000249.4 splice_region, intron
NM_000249.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0980
Publications
3 publications found
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
BP6
Variant 3-37025629-T-TTTTTTTA is Benign according to our data. Variant chr3-37025629-T-TTTTTTTA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 215447.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | NM_000249.4 | MANE Select | c.1039-8_1039-7insTTTTTTA | splice_region intron | N/A | NP_000240.1 | |||
| MLH1 | NM_001354628.2 | c.1039-8_1039-7insTTTTTTA | splice_region intron | N/A | NP_001341557.1 | ||||
| MLH1 | NM_001354629.2 | c.940-8_940-7insTTTTTTA | splice_region intron | N/A | NP_001341558.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | ENST00000231790.8 | TSL:1 MANE Select | c.1039-8_1039-7insTTTTTTA | splice_region intron | N/A | ENSP00000231790.3 | |||
| MLH1 | ENST00000456676.7 | TSL:1 | c.1039-8_1039-7insTTTTTTA | splice_region intron | N/A | ENSP00000416687.3 | |||
| MLH1 | ENST00000413740.2 | TSL:1 | c.1039-8_1039-7insTTTTTTA | splice_region intron | N/A | ENSP00000416476.2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 135298Hom.: 0 Cov.: 19
GnomAD3 genomes
AF:
AC:
0
AN:
135298
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000263 AC: 29AN: 1103206Hom.: 0 Cov.: 20 AF XY: 0.0000220 AC XY: 12AN XY: 545202 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
29
AN:
1103206
Hom.:
Cov.:
20
AF XY:
AC XY:
12
AN XY:
545202
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
3
AN:
21110
American (AMR)
AF:
AC:
0
AN:
17426
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
17586
East Asian (EAS)
AF:
AC:
0
AN:
29082
South Asian (SAS)
AF:
AC:
0
AN:
38366
European-Finnish (FIN)
AF:
AC:
1
AN:
36842
Middle Eastern (MID)
AF:
AC:
0
AN:
3210
European-Non Finnish (NFE)
AF:
AC:
23
AN:
895810
Other (OTH)
AF:
AC:
1
AN:
43774
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000000133157), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.358
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 135288Hom.: 0 Cov.: 19 AF XY: 0.00 AC XY: 0AN XY: 65430
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
135288
Hom.:
Cov.:
19
AF XY:
AC XY:
0
AN XY:
65430
African (AFR)
AF:
AC:
0
AN:
33996
American (AMR)
AF:
AC:
0
AN:
13736
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3320
East Asian (EAS)
AF:
AC:
0
AN:
4932
South Asian (SAS)
AF:
AC:
0
AN:
4464
European-Finnish (FIN)
AF:
AC:
0
AN:
7974
Middle Eastern (MID)
AF:
AC:
0
AN:
244
European-Non Finnish (NFE)
AF:
AC:
0
AN:
63904
Other (OTH)
AF:
AC:
0
AN:
1826
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MLH1: PM2, BP4
Hereditary nonpolyposis colorectal neoplasms Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.